Home > Clinical Trials

Saved trials

Completed
NCT00846365
Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
1,085 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Terminated
NCT01107899
Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes
29 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Acute Coronary Syndromes
Completed
NCT01305369
The Effect of Prasugrel on Bronchial Hyperreactivity and on Markers of Inflammation in Patients With Chronic Asthma
26 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Chronic Asthma
Unknown status
NCT01046461
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer
41 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Solid Tumour
Postoperative Nausea and Vomiting
Completed
NCT01178099
An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults
26 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Anemia, Sickle Cell
Completed
NCT01033071
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
1,071 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Completed
NCT01013012
Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery
94 Enrollment(s)
0 Study location(s)
Interventional (Phase IV)
Nausea
Vomiting
Completed
NCT00185120
Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
152 Enrollment(s)
19 Study location(s)
Interventional (Phase IV)
Hypertension